None listed
Conditions
Brief summary
This study will compare the effect of robotic and open surgery for prostate cancer on functional and oncological outcomes Who is this study for? You may be eligible to join this study if you are aged 18 years or above, are undergoing prostatectomy for prostate cancer at RPA or Concord Hospitals and are clinically suitable for robotic prostatectomy. Study details Participants will either have robotic assisted laparascopic surgery or conventional open surgery as determined by the treating surgeon. All participants will undergo tests to determine urinary and erectile function, biopsies to determine oncological outcomes and questionnaires to assess quality of life. These assessments will be conducted pre-operatively, post-operatively and at certain follow-up timepoints up to 10 years.
Interventions
Robot-Assisted Laparoscopic Prostatectomy (RALP) using "da Vinci Xi" (Registered Trademark) Intuitive Surgical Surgical System (average 3-4hrs duration) by participating surgeons at RPAH.
Sponsors
Sydney Local Health District
Study design
Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adult men aged 18 years and over; 2. Undergoing prostatectomy for prostate cancer at RPA or Concord Hospitals; 3. Clinically suitable for robotic prostatectomy; 4. Cognitively able to give written informed consent for participation; 5. Elective procedure.
Exclusion criteria
1. The patient lacks the ability to consent for themselves; 2. Patients unwilling to undergo pre- and post-operative evaluation according to protocol; 3. Patient or tumour factors precluding robotic surgery.
Outcome results
None listed